Nissay Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $151M | Buy |
163,980
+10,192
| +7% | +$10.3M | 0.8% | 25 |
|
|
2025
Q4 | $165M | Buy |
153,788
+8,275
| +6% | +$7.91M | 0.86% | 20 |
|
|
2025
Q3 | $111M | Sell |
145,513
-28,133
| -16% | -$20.9M | 0.61% | 29 |
|
|
2025
Q2 | $135M | Buy |
173,646
+32,305
| +23% | +$25.1M | 0.79% | 22 |
|
|
2025
Q1 | $117M | Buy |
141,341
+664
| +0.5% | +$553K | 0.76% | 23 |
|
|
2024
Q4 | $110M | Sell |
140,677
-32,105
| -19% | -$26.6M | 0.67% | 26 |
|
|
2024
Q3 | $153M | Sell |
172,782
-42,298
| -20% | -$38M | 0.97% | 17 |
|
|
2024
Q2 | $195M | Sell |
215,080
-7,244
| -3% | -$5.79M | 1.29% | 17 |
|
|
2024
Q1 | $173M | Sell |
222,324
-3,835
| -2% | -$2.73M | 1.2% | 18 |
|
|
2023
Q4 | $132M | Sell |
226,159
-9,044
| -4% | -$5.28M | 1.06% | 17 |
|
|
2023
Q3 | $126M | Sell |
235,203
-38,607
| -14% | -$19.9M | 1.12% | 17 |
|
|
2023
Q2 | $128M | Sell |
273,810
-27,566
| -9% | -$11.6M | 1.11% | 16 |
|
|
2023
Q1 | $103M | Buy |
301,376
+198,923
| +194% | +$67.1M | 0.92% | 19 |
|
|
2022
Q4 | $37.5M | Sell |
102,453
-3,783
| -4% | -$1.34M | 0.36% | 52 |
|
|
2022
Q3 | $34.4M | Buy |
106,236
+3,066
| +3% | +$971K | 0.36% | 49 |
|
|
2022
Q2 | $33.5M | Sell |
103,170
-193
| -0.2% | -$57.9K | 0.33% | 50 |
|
|
2022
Q1 | $29.6M | Buy |
103,363
+1,657
| +2% | +$426K | 0.26% | 62 |
|
|
2021
Q4 | $28.1M | Buy |
101,706
+13,287
| +15% | +$3.37M | 0.22% | 73 |
|
|
2021
Q3 | $20.4M | Buy |
88,419
+7,403
| +9% | +$1.83M | 0.17% | 87 |
|
|
2021
Q2 | $18.6M | Buy |
81,016
+178
| +0.2% | +$35.8K | 0.16% | 90 |
|
|
2021
Q1 | $15.1M | Sell |
80,838
-2,149
| -3% | -$420K | 0.15% | 94 |
|
|
2020
Q4 | $14M | Sell |
82,987
-5,435
| -6% | -$811K | 0.21% | 100 |
|
|
2020
Q3 | $13.1M | Sell |
88,422
-12,642
| -13% | -$1.96M | 0.22% | 97 |
|
|
2020
Q2 | $16.6M | Sell |
101,064
-5,543
| -5% | -$851K | 0.32% | 80 |
|
|
2020
Q1 | $14.8M | Buy |
106,607
+2,311
| +2% | +$318K | 0.38% | 75 |
|
|
2019
Q4 | $13.7M | Sell |
104,296
-4,949
| -5% | -$574K | 0.3% | 86 |
|
|
2019
Q3 | $12.2M | Sell |
109,245
-538
| -0.5% | -$59.9K | 0.3% | 82 |
|
|
2019
Q2 | $12.2M | Sell |
109,783
-11,935
| -10% | -$1.41M | 0.31% | 82 |
|
|
2019
Q1 | $15.8M | Sell |
121,718
-5,404
| -4% | -$657K | 0.42% | 57 |
|
|
2018
Q4 | $14.7M | Buy |
127,122
+1,949
| +2% | +$218K | 0.45% | 47 |
|
|
2018
Q3 | $13.4M | Buy |
125,173
+1,732
| +1% | +$173K | 0.36% | 67 |
|
|
2018
Q2 | $10.5M | Sell |
123,441
-13,149
| -10% | -$1.08M | 0.31% | 76 |
|
|
2018
Q1 | $10.6M | Buy |
136,590
+4,356
| +3% | +$351K | 0.33% | 71 |
|
|
2017
Q4 | $11.2M | Buy |
+132,234
| New | +$11.3M | 0.34% | 66 |
|
Other funds holding LLY
VCM
VPM
Nissay Asset Management's LLY Position: Q1 2026 in Review
Nissay Asset Management increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $10.3M and bringing the position to 163,980 shares worth $151M. The position accounts for 0.8% of the portfolio, ranked #25.
Nissay Asset Management first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $195M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Nissay Asset Management held 163,980 shares of Eli Lilly worth $151M as of Q1 2026.
- Nissay Asset Management bought 10,192 Eli Lilly shares in Q1 2026, an estimated $10.3M.
- Eli Lilly made up 0.8% of Nissay Asset Management's portfolio in Q1 2026, its #25 holding.
- Nissay Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- Nissay Asset Management's Eli Lilly position peaked at $195M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.